Your browser doesn't support javascript.
loading
Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease.
Wells, Jack A; Holmes, Holly E; O'Callaghan, James M; Colgan, Niall; Ismail, Ozama; Fisher, Elizabeth Mc; Siow, Bernard; Murray, Tracey K; Schwarz, Adam J; O'Neill, Michael J; Collins, Emily C; Lythgoe, Mark F.
Afiliação
  • Wells JA; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
  • Holmes HE; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
  • O'Callaghan JM; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
  • Colgan N; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
  • Ismail O; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
  • Fisher EM; Department of Neurodegenerative Disease, Institute of Neurology, UCL, London, UK.
  • Siow B; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
  • Murray TK; Eli Lilly & Co. Ltd, Erl Wood Manor, Windlesham, Surrey, UK.
  • Schwarz AJ; Tailored Therapeutics, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
  • O'Neill MJ; Eli Lilly & Co. Ltd, Erl Wood Manor, Windlesham, Surrey, UK.
  • Collins EC; Tailored Therapeutics, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
  • Lythgoe MF; UCL Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
J Cereb Blood Flow Metab ; 35(3): 359-62, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25515210
ABSTRACT
Vascular abnormalities are a key feature of Alzheimer's disease (AD). Imaging of cerebral vascular reactivity (CVR) is a powerful tool to investigate vascular health in clinical populations although the cause of reduced CVR in AD patients is not fully understood. We investigated the specific role of tau pathology in CVR derangement in AD using the rTg4510 mouse model. We observed an increase in CVR in cortical regions with tau pathology. These data suggest that tau pathology alone does not produce the clinically observed decreases in CVR and implicates amyloid pathology as the dominant etiology of impaired CVR in AD patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Circulação Cerebrovascular / Proteínas tau / Doença de Alzheimer Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Circulação Cerebrovascular / Proteínas tau / Doença de Alzheimer Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article